In conclusion, our current study reveals a direct molecular link between Parkin and protein degradation in the control of the NF-κB pathway and may provide a novel UPS-dependent strategy for the treatment of HCC by induction of apoptosis. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.